{"entity":{"type":"insider","cik":"0001774588","url":"/insider/0001774588","json_url":"/insider/0001774588.json","name":"Stephan Dietrich A","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":4,"n_filings":4,"first":"2020-05-04","last":"2021-04-27","span_basis":"filed_date"},"name_variants":[{"name":"Stephan Dietrich A","source":"filing","n_filings":4,"first_seen":"2020-05-04","last_seen":"2021-04-27"}],"transactions":[{"id":4129889,"accession":"0001104659-21-055581","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-055581","line_url":"/filing/0001104659-21-055581#line-1","is_derivative":false,"issuer_cik":"0001173281","issuer_name":"NeuBase Therapeutics, Inc.","issuer_ticker":"NBSE","issuer_name_source":null,"issuer_url":"/issuer/0001173281","owner_cik":"0001774588","owner_name":"Stephan Dietrich A","owner_display_name":"Stephan Dietrich A","owner_url":"/insider/0001774588","role":"Director, Officer (President and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12000.0,"shares_display":"12,000","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":60000.0,"total_display":"60,000.00","total_whole":"60,000","shares_owned_after":24525.0,"shares_owned_after_display":"24,525","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-26","filed_date":"2021-04-27","scope":"insider"},{"id":2518964,"accession":"0001104659-20-071857","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-071857","line_url":"/filing/0001104659-20-071857#line-1","is_derivative":false,"issuer_cik":"0001173281","issuer_name":"NeuBase Therapeutics, Inc.","issuer_ticker":"NBSE","issuer_name_source":null,"issuer_url":"/issuer/0001173281","owner_cik":null,"owner_name":"Stephan Dietrich A; Lipizzaner LLC","owner_display_name":"Stephan Dietrich A","owner_url":null,"role":"Director, Officer (President and CEO), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1275.0,"shares_display":"1,275","price_per_share":7.7339,"price_display":"7.73","price_state":"stated","total_value":9860.7225,"total_display":"9,860.72","total_whole":"9,861","shares_owned_after":12525.0,"shares_owned_after_display":"12,525","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-09","filed_date":"2020-06-10","scope":"insider"},{"id":2639407,"accession":"0001104659-20-065897","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-065897","line_url":"/filing/0001104659-20-065897#line-1","is_derivative":false,"issuer_cik":"0001173281","issuer_name":"NeuBase Therapeutics, Inc.","issuer_ticker":"NBSE","issuer_name_source":null,"issuer_url":"/issuer/0001173281","owner_cik":null,"owner_name":"Stephan Dietrich A; Lipizzaner LLC","owner_display_name":"Stephan Dietrich A","owner_url":null,"role":"Director, Officer (President and CEO), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1250.0,"shares_display":"1,250","price_per_share":8.0888,"price_display":"8.09","price_state":"stated","total_value":10111.0,"total_display":"10,111.00","total_whole":"10,111","shares_owned_after":11250.0,"shares_owned_after_display":"11,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-21","filed_date":"2020-05-26","scope":"insider"},{"id":3212483,"accession":"0001104659-20-056160","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-056160","line_url":"/filing/0001104659-20-056160#line-1","is_derivative":false,"issuer_cik":"0001173281","issuer_name":"NeuBase Therapeutics, Inc.","issuer_ticker":"NBSE","issuer_name_source":null,"issuer_url":"/issuer/0001173281","owner_cik":null,"owner_name":"Stephan Dietrich A; Lipizzaner LLC","owner_display_name":"Stephan Dietrich A","owner_url":null,"role":"Director, Officer (President and CEO), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":60000.0,"total_display":"60,000.00","total_whole":"60,000","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-30","filed_date":"2020-05-04","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":1,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":1},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001173281","name":"NeuBase Therapeutics, Inc.","url":"/issuer/0001173281","role":"Director, Officer (President and CEO), Ten percent owner","n_filings":4,"first_seen":"2020-05-04","last_seen":"2021-04-27"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001774588","retrieved_at":"2026-08-27T22:11:14+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}